Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000372349

Medchemexpress LLC E-64 (proteinase inhibitor E 64) | 66701-25-5 | C15H27N5O5 | 1 ML
SDP

Catalog No. 5000372349
Encompass_Preferred

E-64 is a potent irreversible inhibitor against general cysteine proteases, with an IC50 of 9 nM for papain. It acts as a cathepsin B-specific inhibitor and its binding modes have been studied at an atomic level with various proteases including papain, actinidin, cathepsin L, and cathepsin K. This compound is widely utilized as a potent and irreversible covalent-type inhibitor for a range of cysteine proteases.

  • Potent irreversible inhibitor against general cysteine proteases
  • IC50 of 9 nM for papain
  • Cathepsin B-specific inhibitor
  • Inhibits various cysteine proteases including papain, ficin, actinidin, cathepsin B, and L

Catalog No. 50-003-72349 Supplier Medchemexpress LLC Supplier No. HY1528210MM/1ML
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

E-64 is a potent irreversible inhibitor against general cysteine proteases, with an IC50 of 9 nM for papain. It acts as a cathepsin B-specific inhibitor and its binding modes have been studied at an atomic level with various proteases including papain, actinidin, cathepsin L, and cathepsin K. This compound is widely utilized as a potent and irreversible covalent-type inhibitor for a range of cysteine proteases.

  • Potent irreversible inhibitor against general cysteine proteases
  • IC50 of 9 nM for papain
  • Cathepsin B-specific inhibitor
  • Inhibits various cysteine proteases including papain, ficin, actinidin, cathepsin B, and L

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.